Hydrochlorothiazide adverse effects
Pro Research Analysisby 
Searched over 200M research papers
Adverse Effects of Hydrochlorothiazide: A Comprehensive Review
Introduction to Hydrochlorothiazide Adverse Effects
Hydrochlorothiazide (HCTZ) is a widely used thiazide diuretic for managing hypertension. Despite its efficacy, HCTZ is associated with several adverse effects that can impact patient health. This article synthesizes findings from multiple studies to provide a detailed overview of these adverse effects.
Metabolic Adverse Effects: Glucose and Lipid Metabolism
Hydrochlorothiazide has been shown to negatively affect glucose and lipid metabolism. In a study comparing HCTZ with captopril, HCTZ decreased insulin-mediated glucose disposal and increased basal insulin concentration, suggesting reduced insulin sensitivity. Additionally, HCTZ significantly increased serum total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyceride levels . Another study confirmed that even low doses of HCTZ could lead to significant elevations in total cholesterol, LDL cholesterol, and apolipoprotein B, while reducing apolipoprotein A1 . These metabolic changes may contribute to an increased risk of diabetes mellitus and coronary heart disease Pollare1989Mckenney1986.
Allergic Reactions and Hypersensitivity
Severe allergic reactions to HCTZ, although rare, can be life-threatening. A case study described a patient who experienced symptoms mimicking septic shock due to an allergic reaction to HCTZ. This reaction was suspected to be related to the patient's predisposition to drug allergies rather than cross-sensitivity with other sulfonamide drugs . Another report highlighted noncardiogenic pulmonary edema as a serious adverse reaction, occurring within minutes to hours after HCTZ ingestion, predominantly in women .
Renal Adverse Effects
The addition of HCTZ to angiotensin-converting enzyme (ACE) inhibitors in rats with myocardial infarction resulted in significant renal damage. This included increased plasma creatinine levels, severe renal interstitial lesions, tubular dilatation, and fibrosis. These renal changes were associated with increased mortality in rats with the highest plasma creatinine levels . This suggests that HCTZ can detrimentally affect renal function and structure, particularly when combined with other medications.
Electrolyte Imbalances
HCTZ is known to cause electrolyte abnormalities, including hypokalemia (low potassium levels) and hypomagnesemia (low magnesium levels). A study on elderly patients with systolic hypertension reported reduced serum potassium and magnesium concentrations with long-term HCTZ use . Another study found that high doses of HCTZ significantly reduced serum potassium levels, while low doses did not .
Cognitive and Psychomotor Effects
In a placebo-controlled trial, HCTZ was associated with less improvement in cognitive and psychomotor skills compared to other antihypertensive treatments. Specifically, patients on HCTZ showed less improvement on the block design subscale of the Wechsler Adult Intelligence Scale-Revised . This suggests that HCTZ may have a negative impact on cognitive function.
Common Adverse Events in Combination Therapy
When combined with eprosartan, HCTZ was generally well-tolerated, but common adverse events included headache, dizziness, and upper respiratory tract infections. These adverse events were mostly mild to moderate and occurred early in the treatment .
Impact of Abdominal Obesity
Patients with abdominal obesity are more susceptible to adverse metabolic effects from HCTZ. A study found that hypertensive patients with abdominal obesity had a higher incidence of impaired fasting glucose, elevated triglycerides, and new-onset diabetes mellitus after HCTZ treatment . This highlights the need for careful monitoring of metabolic parameters in obese patients on HCTZ.
Conclusion
Hydrochlorothiazide, while effective for hypertension management, is associated with several adverse effects, including metabolic disturbances, allergic reactions, renal damage, electrolyte imbalances, and cognitive effects. Clinicians should be aware of these potential risks and monitor patients closely, especially those with predisposing factors such as obesity or a history of drug allergies.
Sources and full results
Most relevant research papers on this topic